Apyx Medical Corp(APYX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:00 PM ET (Korea 10/31 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.2 | Insider Own | 13.56% | Shs Outstand | 42.1M | Perf Week | 9.7% |
| Market Cap | 0.11B | Forward P/E | - | EPS next Y | 5.03% | Insider Trans | - | Shs Float | 36.4M | Perf Month | 4% |
| Enterprise Value | 0.12B | PEG | - | EPS next Q | -0.09 | Inst Own | 55.59% | Short Float | 0.59% | Perf Quarter | -37.8% |
| Income | -0.01B | P/S | 1.88 | EPS this Y | 1.85% | Inst Trans | 1.59% | Short Ratio | 1.5 | Perf Half Y | -15.03% |
| Sales | 0.06B | P/B | 10.27 | EPS next 5Y | 28.19% | ROA | -14.48% | Short Interest | 0.21M | Perf YTD | -25.71% |
| Book/sh | 0.25 | P/C | 3.97 | EPS past 3/5Y | 25.94% 4.74% | ROE | -96.38% | 52W High | -48.82% ($5.08) | Perf Year | -11.86% |
| Cash/sh | 0.66 | P/FCF | - | Sales past 3/5Y | 5.89% 13.78% | ROIC | -17.33% | 52W Low | 15.56% ($2.25) | Perf 3Y | 13.54% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 55.35% | Gross Margin | 38.7% | Volatility(W/M) | 5.39% 6.01% | Perf 5Y | -81.82% |
| Dividend TTM | - | EV/Sales | 2.09 | Sales Y/Y TTM | 25.59% | Oper. Margin | -6.06% | ATR (14) | 0.16 | Perf 10Y | -53.15% |
| Dividend Ex-Date | - | Quick Ratio | 4.53 | EPS Q/Q | 20.26% | Profit Margin | -14.78% | RSI (14) | 49.16 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.68 | Sales Q/Q | 22.08% | SMA20 | 2.8% ($2.53) | Beta | 1.48 | Target Price | $6.5 |
| Payout | - | Debt/Eq | 3.72 | Earnings | 2026/11/5 | SMA50 | -6.13% ($2.77) | Rel Volume | 0.27 | Prev Close | $2.69 |
| Employees | 205 | LT Debt/Eq | 3.67 | EPS/Sales Surpr. | 14.63% 5.38% | SMA200 | -27.8% ($3.6) | Avg Volume(3M) | 0.14M | Price | $2.6 |
| IPO | 1999/2/22 | Option/Short | Yes/Yes | Trades | 481 | Volume | 38,095 | Change | -3.35% |
⚡ Apyx Medical is an energy-based medical device company headquartered in Florida, USA. Its ticker is APYX. The company develops aesthetic and surgical equipment using helium plasma technology, supplying it to procedure sites such as plastic surgery and dermatology practices, and operates both its own branded procedure equipment and an OEM (contract manufacturing) business.
Over the past 1 year, on the lower side
49% below its 1-year high.
Traded less than usual. That is 27% of its average volume.
Next earnings report: November 5
5 days to go.
APYX has a sound balance sheet but weak earning power
Of every $100 in sales, $6.06 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +1.9% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $188. Peers typically go for $143.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -81.8%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 55.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #85 of 142 in the industry
Based on market cap of $110M.
CATX#82 Perspective Therapeutics Inc $131M PER - 
LUNG#83 Pulmonx Corp $129M PER - 
OWLT#84 Owlet Inc $118M PER - APYX#85 Apyx Medical Corp $110M PER - 
NYXH#86 Nyxoah SA $89M PER - 
FAQ
What kind of company is APYX?
APYX belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of APYX?
The market cap of APYX is approximately $110M, ranking 4,408 within its sector.
What is the 52-week high and low for APYX?
APYX has recorded a 52-week high of $5.08 and a low of $2.25.
